BACKGROUND: Activation of the complement system is part of the dysregulated immune response in sepsis. The mannose-binding lectin-associated serine proteases (MASP)-1 and -2 activate the lectin pathway of the complement system. Besides, these proteins can activate coagulation in vitro. However, the role of the lectin pathway proteins in the development of sepsis-related disseminated intravascular coagulation (DIC) is only sparsely investigated. AIM: This article investigates the association between lectin pathway proteins and coagulation disturbances in septic shock patients. MATERIALS AND METHODS: We included 36 septic shock patients from the intensive care unit, Aarhus University Hospital, Denmark. Blood samples were obtained within 24 hours after admission (day 1), and subsequently on day 2 and day 3. Plasma concentrations of mannose-binding lectin (MBL), H-ficolin, M-ficolin, CL-L1, CL-K1, MASP-1, -2 and -3, MBL-associated proteins of 19 and 44 kDa as well as complement factor C3dg were assessed. Standard coagulation parameters, thrombin generation, thrombin-anti-thrombin (TAT) complex and pro-thrombin fragment 1 + 2 were measured. Sequential Organ Failure Assessment (SOFA) score, DIC score and 30-day mortality were assessed. RESULTS: Reduced MASP-1 plasma concentration was associated with DIC score ≥5 (p = 0.02), impaired thrombin generation (p = 0.03) and lower plasma TAT complex levels (p = 0.03). No association was found between lectin pathway proteins and SOFA score or 30-day mortality. CONCLUSION: Reduced MASP-1 concentrations were associated with impaired coagulation in septic shock patients. This indicates that increased MASP-1 activation and consumption is associated with the more severe coagulation disturbances in sepsis and points to a possible role for MASP-1 in sepsis-related DIC. Georg Thieme Verlag KG Stuttgart · New York.
BACKGROUND: Activation of the complement system is part of the dysregulated immune response in sepsis. The mannose-binding lectin-associated serine proteases (MASP)-1 and -2 activate the lectin pathway of the complement system. Besides, these proteins can activate coagulation in vitro. However, the role of the lectin pathway proteins in the development of sepsis-related disseminated intravascular coagulation (DIC) is only sparsely investigated. AIM: This article investigates the association between lectin pathway proteins and coagulation disturbances in septic shockpatients. MATERIALS AND METHODS: We included 36 septic shockpatients from the intensive care unit, Aarhus University Hospital, Denmark. Blood samples were obtained within 24 hours after admission (day 1), and subsequently on day 2 and day 3. Plasma concentrations of mannose-binding lectin (MBL), H-ficolin, M-ficolin, CL-L1, CL-K1, MASP-1, -2 and -3, MBL-associated proteins of 19 and 44 kDa as well as complement factor C3dg were assessed. Standard coagulation parameters, thrombin generation, thrombin-anti-thrombin (TAT) complex and pro-thrombin fragment 1 + 2 were measured. Sequential Organ Failure Assessment (SOFA) score, DIC score and 30-day mortality were assessed. RESULTS: Reduced MASP-1 plasma concentration was associated with DIC score ≥5 (p = 0.02), impaired thrombin generation (p = 0.03) and lower plasma TAT complex levels (p = 0.03). No association was found between lectin pathway proteins and SOFA score or 30-day mortality. CONCLUSION: Reduced MASP-1 concentrations were associated with impaired coagulation in septic shockpatients. This indicates that increased MASP-1 activation and consumption is associated with the more severe coagulation disturbances in sepsis and points to a possible role for MASP-1 in sepsis-related DIC. Georg Thieme Verlag KG Stuttgart · New York.
Authors: Nicholas R Medjeral-Thomas; Anne Troldborg; Annette G Hansen; Jack Gisby; Candice L Clarke; Maria Prendecki; Stephen P McAdoo; Eleanor Sandhu; Liz Lightstone; David C Thomas; Michelle Willicombe; Marina Botto; James E Peters; Matthew C Pickering; Steffen Thiel Journal: Front Immunol Date: 2021-04-29 Impact factor: 8.786
Authors: Songqiang Pang; Yao Song; Jinqiang Yang; Sen Li; Yaqiang He; Gongtang Luo Journal: Evid Based Complement Alternat Med Date: 2021-09-06 Impact factor: 2.629
Authors: Markus Korsholm Kristensen; Marco Bo Hansen; Martin Bruun Madsen; Cecilie Bo Hansen; Katrine Pilely; Ole Hyldegaard; Peter Garred Journal: Front Immunol Date: 2020-01-31 Impact factor: 7.561